Inqovi for AML treatment ...

Prostate cancer (PCa) remains a significant global health challenge, with rising morbidity rates and poor prognosis associated with advanced stages ...

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER THIS POSITIVE DECISION FROM THE USA ...

Docetaxel rechallenge was associated with longer OS and time to subsequent treatment or death compared with cabazitaxel for patinets with chemonaïve mCRPC.

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET ...

Cardio-oncologists should incorporate vascular prevention in their care, especially for those without protective hormones.

The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...

At the San Antonio Breast Cancer Symposium, researchers discussed how results from HER2CLIMB-05 may inform first-line ...

Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...

The MarketWatch News Department was not involved in the creation of this content. VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary -- The global ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...